-
Symbol
-
TCRX on Nasdaq
-
Investment type
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
3.6M shares
-
Security Ownership
-
6.9%
K2 HealthVentures Equity Trust LLC ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)
2025-02-14 - K2 HealthVentures Equity Trust LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.6M shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX).
This represents 6.9% percent ownership of the company.